Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. A Prospective Phase II Pilot Trial of the German Rectal Cancer Study Group

NCT03561142 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03561142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. A Prospective Phase II Pilot Trial of the German Rectal Cancer Study Group
Lead sponsor
University Hospital Tuebingen
Phase
Phase 2
Overall status
Unknown status
Start date
June 15, 2018
Completion date
April 16, 2024
Enrollment
94 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer, rectal cancer stage ii, rectal cancer stage iii, rectal neoplasms